H.R. 2985 (113th): Combination Drug Development Incentive Act of 2013
Aug 2, 2013
113th Congress, 2013–2015
Died in a previous Congress
This bill was introduced on August 2, 2013, in a previous session of Congress, but was not enacted.
Representative for Utah's 3rd congressional district
Read Text »
Last Updated: Aug 2, 2013
Length: 5 pages
About the bill
- Full Title
To amend section 505 of the Federal Food, Drug, and Cosmetic Act to provide incentives for the development of new combination drugs.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Jan 20, 2015
- What is a bill?
The “H.R.” in “H.R. 2985” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
4 cosponsors (3R, 1D) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2985 — 113th Congress: Combination Drug Development Incentive Act of 2013. Retrieved from https://www.govtrack.us/congress/bills/113/hr2985
“H.R. 2985 — 113th Congress: Combination Drug Development Incentive Act of 2013.” www.GovTrack.us. 2013. March 1, 2015 <https://www.govtrack.us/congress/bills/113/hr2985>
|title=H.R. 2985 (113th)
|accessdate=March 1, 2015
|author=113th Congress (2013)
|date=August 2, 2013
|quote=Combination Drug Development Incentive Act of 2013